8-K: Roth CH Acquisition Co. Adjourns Shareholder Meetings to Facilitate OTC Listing

Roth CH Acquisition Co. has adjourned its shareholder meetings to April 17, 2024, to allow additional time to complete its OTC listing.

Summary

• Roth CH Acquisition Co. convened an Extraordinary General Meeting and a Separate Class Meeting on April 10, 2024.
• The only proposals voted on were to adjourn the meetings to April 17, 2024, to allow the company more time to complete its OTC listing.
• The meetings will reconvene on April 17, 2024, at 9:30 a.m. and 10:00 a.m. Eastern Time, respectively, at the offices of Loeb & Loeb LLP in New York.
• The meetings can also be accessed via teleconference.
• The company will not solicit additional votes or accept new redemption requests during the adjournment.
• Previously submitted proxies will be voted at the adjourned meetings unless revoked.
• If Proposal 1 is implemented, the company will distribute remaining trust account funds to shareholders after deducting taxes and up to $100,000 for dissolution expenses.
• Shareholders will also be allowed to retain 10% of their shares if they participate in the 90% redemption.
• The transfer agent intends to process both the redemption related to Proposal 1 and the automatic 90% redemption simultaneously, expected within 2-3 weeks of Proposal 1 adoption.
• The trust account will be liquidated at the same time as the redemption of Public Shares.
• Shareholders who redeem in connection with Proposal 1 will not retain any Public Shares, while those participating in the 90% redemption will retain 10% of their Public Shares.
• The company may continue to accept redemption reversal requests before the adjourned meetings.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While there is a delay, the company is taking steps to complete its OTC listing and distribute funds to shareholders. The option for shareholders to retain 10% of their shares is also a positive.

Positives

• The company is taking steps to complete its OTC listing.
• Shareholders will receive a distribution of remaining trust account funds.
• Shareholders have the option to retain 10% of their shares through the 90% redemption.
• The company is allowing redemption reversals prior to the adjourned meetings.

Negatives

• The shareholder meetings were adjourned, indicating a delay in the original timeline.
• The company is incurring dissolution expenses of up to $100,000.

Risks

• The delay in completing the OTC listing could impact the company's timeline and strategy.
• The dissolution expenses will reduce the amount distributed to shareholders.
• There is a risk that the OTC listing may not be completed as planned.

Future Outlook

The company intends to complete its OTC listing and distribute remaining trust account funds to shareholders after deducting taxes and dissolution expenses. The redemption of shares is expected to occur within 2-3 weeks of the adoption of Proposal 1.

Management Comments

• The company is adjourning the meetings to allow additional time to complete its OTC listing.
• The company will not solicit additional votes or accept new redemption requests during the adjournment.
• The company may continue to accept requests for redemption reversals prior to the time of the adjourned Meetings.

Industry Context

This announcement is specific to Roth CH Acquisition Co. and its efforts to complete an OTC listing. It does not directly relate to broader industry trends, but it does highlight the challenges and complexities involved in such transactions.

Comparison to Industry Standards

• The adjournment of shareholder meetings to facilitate an OTC listing is not uncommon for companies undergoing similar transitions.
• The redemption process and distribution of trust account funds are standard procedures for SPACs that are not completing a business combination.
• The 2-3 week timeframe for redemption processing is within the typical range for such transactions.

Stakeholder Impact

• Shareholders will receive a distribution of remaining trust account funds.
• Shareholders have the option to retain 10% of their shares through the 90% redemption.
• The delay in completing the OTC listing may impact shareholders' timelines.

Next Steps

• The company will reconvene the shareholder meetings on April 17, 2024.
• The company will complete its OTC listing.
• The company will distribute remaining trust account funds to shareholders.
• The company will process the redemption of shares within 2-3 weeks of the adoption of Proposal 1.

Key Dates

Keywords

OTC listing, shareholder meeting, redemption, trust account, adjournment, dissolution, proxy, USCTU, USCT, USCTW